Abstract: The invention relates to substituted S-alaninate derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.

Abstract: The invention relates to substituted S-alaninate derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular vascular disorders, preferably thrombotic or thromboembolic disorders and/or thrombotic or thromboembolic complications.

Abstract: A smoking pipe is provided. The smoking pipe includes an upper housing with a lower housing removably attached to the upper housing. An insert is located between the upper housing and the lower housings so that the upper and lower housings and the insert form an interior channel that directs air introduced to the interior channel to move toward a user, then away from the user, then toward the user again.

Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.

Abstract: A smoking pipe is provided. The smoking pipe includes an upper housing with a lower housing removably attached to the upper housing. An insert is located between the upper housing and the lower housings so that the upper and lower housings and the insert form an interior channel that directs air introduced to the interior channel to move toward a user, then away from the user, then toward the user again.

Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for preparation thereof, and also to the use thereof for production of medicaments for treatment and/or prophylaxis of diseases, especially of cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: The present invention relates to antibodies capable of binding to the coagulation Factor XI and/or its activated form factor XIa and methods of use thereof, particularly methods of use as agents inhibiting platelet aggregation and by this inhibits thrombus formation.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: A method for providing a service containing facilities in a peer-to-peer network comprising peer devices is provided. The peer devices may be associated with groups, each group being defined by a pre-determined facility. The pre-determined facility may be executed by each peer device associated with a respective group, and a selected peer device of a group executes the respective facility. A sequence of facilities and specifications to be executed is publicized in the peer-to-peer network, on the peer devices executing the respective facility by a peer device requesting the combined service, and the selection of the selected peer devices is carried out according to the publicized sequence and the publicized specifications.

Abstract: A vending machine is provided. The vending machine includes a number of bins, with each bin sized to contain a consumable product. The vending machine also includes a consumable product collection area, with the consumable product collection area accessible by a vending machine user. A conveyor communicates at least a portion of each of the bins, with the conveyor positioned to receive the consumable product from the bin and transport the consumable product to the consumable product collection area. The vending machine also includes an interface structured to receive a currency from the vending machine user to purchase at least one of the consumable products and a controller that activates the conveyor to transport the consumable product to the consumable product collection area.

Abstract: The invention relates to substituted benzoxazoles and to processes for their preparation and to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular of cardiovascular disorders, preferably of thrombotic or thromboembolic disorders.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: The invention relates to substituted oxopyridine derivatives and to processes for their preparation, and also to their use for preparing medicaments for the treatment and/or prophylaxis of diseases, in particular cardiovascular disorders, preferably thrombotic or thromboembolic disorders, and oedemas, and also ophthalmic disorders.

Abstract: In a method for controlling the electrical power consumption of a plurality of power consumers in a power grid, the power consumers represent network nodes of a communication network made of a plurality of network nodes, in which the power consumers communicate with each other. Each of the network nodes estimates the total power consumption of the network nodes based on the exchange of information with one other network node. Each network node having an additional power demand which increases a required amount of power, compares the total power consumption estimated by the network node plus the required amount of power to a predefined total power demand of the network nodes and initiates a delivery of the required amount of power from a power provider when the estimated total power demand thereof plus the required amount of power is less than the predefined total power demand by a threshold value.